Q32 Bio Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Q32 Bio Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2024.
  • Q32 Bio Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$17.6M, a 25.4% decline year-over-year.
  • Q32 Bio Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$120M, a 96.5% decline year-over-year.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$113M, a 2157% decline from 2022.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.01M, a 94.8% increase from 2021.
  • Q32 Bio Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$95.8M, a 25.6% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$120M -$17.6M -$3.56M -25.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$116M -$17M -$11.2M -192% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$105M $1.03M +$7.87M Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$113M -$86.3M -$52M -152% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$61M -$14M +$19.7M +58.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$80.7M -$5.81M +$23.3M +80% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$104M -$6.84M -$98.9M -107% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$5.01M -$34.3M -$712K -2.12% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$4.29M -$33.7M -$3.12M -10.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.18M -$29.1M +$1.41M +4.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$2.59M $92.1M +$93.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$95.8M -$33.6M -$3.79M -12.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$92M -$30.6M -$2.38M -8.42% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$89.6M -$30.5M +$4.84M +13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$94.4M -$1.07M +$34.3M +97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$129M -$29.8M -$5.62M -23.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$123M -$28.2M +$1.4M +4.71% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$124M -$35.3M -$9.07M -34.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$115M -$35.3M -$11.5M -48.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$104M -$24.2M -$5.38M -28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$98.5M -$29.6M -$15.5M -109% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$83.1M -$26.3M -$13.8M -111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$69.2M -$23.9M -$13.6M -133% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$55.6M -$18.8M -$6.88M -57.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$48.7M -$14.1M -$7.62M -117% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$41.1M -$12.4M -$6.42M -107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$34.7M -$10.2M -$4.66M -83.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$30M -$11.9M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$6.53M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$5.55M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.